Cargando…

A novel marker integrating multiple genetic alterations better predicts platinum sensitivity in ovarian cancer than HRD score

Introduction: Platinum-based chemotherapy is the first-line treatment strategy for ovarian cancer patients. The dismal prognosis of ovarian cancer was shown to be stringently associated with the heterogeneity of tumor cells in response to this therapy, therefore understanding platinum sensitivity in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Fan, Wei, Wei, Li, Ganghua, Lan, Qiongyu, Liu, Xiwei, Gao, Lin, Zhang, Chao, Fan, Jiangtao, Li, Jundong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508345/ https://www.ncbi.nlm.nih.gov/pubmed/37732324 http://dx.doi.org/10.3389/fgene.2023.1240068

Ejemplares similares

HRD-MILN: Accurately estimate tumor homologous recombination deficiency status from targeted panel sequencing data
por: Wang, Xuwen, et al.
Publicado: (2022)

Cryo-EM structure of the protein-conducting ERAD channel Hrd1 in complex with Hrd3
por: Schoebel, Stefan, et al.
Publicado: (2017)

Efficacy of platinum-based chemotherapy in metastatic breast cancer and HRD biomarkers: utility of exome sequencing
por: Galland, Loïck, et al.
Publicado: (2022)

Increased HRD score in cisplatin resistant penile cancer cells
por: Winkelmann, Ria, et al.
Publicado: (2022)

Loss of HRD functional phenotype impedes immunotherapy and can be reversed by HDAC inhibitor in ovarian cancer
por: Yang, Dong, et al.
Publicado: (2023)

Implementing HRD technology /
Publicado: (1999)

Locally Performed HRD Testing for Ovarian Cancer? Yes, We Can!
por: Magliacane, Gilda, et al.
Publicado: (2022)

HRD Testing of Ovarian Cancer in Routine Practice: What Are We Dealing With?
por: Kekeeva, Tatiana, et al.
Publicado: (2023)

Profiling of the genetic features of Chinese patients with gastric cancer with HRD germline mutations in a large-scale retrospective study
por: Zhang, Chenghai, et al.
Publicado: (2023)

A seven-gene prognostic model for platinum-treated ovarian carcinomas
por: Sabatier, R, et al.
Publicado: (2011)

Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer
por: Lotan, Tamara L., et al.
Publicado: (2021)

Preoperative PET/CT score can predict incomplete resection after debulking surgery for advanced serous ovarian cancer better than CT score, MTV, tumor markers and hematological markers
por: Wang, Jie, et al.
Publicado: (2022)

The role of Hrd1 in ultraviolet (UV) radiation induced photoaging
por: Jin, Yi, et al.
Publicado: (2020)

Adipose tissue area as a predictor for the efficacy of apatinib in platinum-resistant ovarian cancer: an exploratory imaging biomarker analysis of the AEROC trial
por: Huang, Xin, et al.
Publicado: (2020)

HRD effects on first-line adjuvant chemotherapy and PARPi maintenance therapy in Chinese ovarian cancer patients
por: Li, Lei, et al.
Publicado: (2023)

Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells
por: Roberts, D, et al.
Publicado: (2005)

Endoplasmic Reticulum Degradation Requires Lumen to Cytosol Signaling: Transmembrane Control of Hrd1p by Hrd3p
por: Gardner, Richard G., et al.
Publicado: (2000)

Non-Coding RNA Networks in Pulmonary Hypertension
por: Zang, Hongbin, et al.
Publicado: (2021)

Spatial Transcriptomics for Tumor Heterogeneity Analysis
por: Li, Qiongyu, et al.
Publicado: (2022)

Homologous recombination deficiency (HRD) testing in ovarian cancer clinical practice: a review of the literature
por: Frey, Melissa K., et al.
Publicado: (2017)

Putative Interaction Proteins of the Ubiquitin Ligase Hrd1 in Magnaporthe oryzae
por: Jiang, Haolang, et al.
Publicado: (2018)

In-house testing for homologous recombination repair deficiency (HRD) testing in ovarian carcinoma: a feasibility study comparing AmoyDx HRD Focus panel with Myriad myChoiceCDx assay
por: Fumagalli, Caterina, et al.
Publicado: (2022)

A Hrd way for MHC-II expression
por: Melo-Cardenas, Johanna, et al.
Publicado: (2015)

Homologous Recombination Deficiency (HRD) in Cutaneous Oncology
por: Akinjiyan, Favour A., et al.
Publicado: (2023)

Integrating cell cycle score for precise risk stratification in ovarian cancer
por: Chen, Lingying, et al.
Publicado: (2022)

The prevalence of homologous recombination deficiency (HRD) in various solid tumors and the role of HRD as a single biomarker to immune checkpoint inhibitors
por: Kim, Hana, et al.
Publicado: (2021)

The ER membrane-anchored ubiquitin ligase Hrd1 is a positive regulator of T-cell immunity
por: Xu, Yuanming, et al.
Publicado: (2016)

Implementing HRD Testing in Routine Clinical Practice on Patients with Primary High-Grade Advanced Ovarian Cancer
por: Heitz, Florian, et al.
Publicado: (2023)

Genetic interaction networks: better understand to better predict
por: Boucher, Benjamin, et al.
Publicado: (2013)

Identification of necroptosis subtypes and development of necroptosis-related risk score model for in ovarian cancer
por: Ji, Chen, et al.
Publicado: (2022)

Modularity of the Hrd1 ERAD complex underlies its diverse client range
por: Kanehara, Kazue, et al.
Publicado: (2010)

Identification of platinum resistance-related gene signature for prognosis and immune analysis in bladder cancer
por: Li, Sheng, et al.
Publicado: (2023)

Markers of Oxidative Stress and Inflammation in Ascites and Plasma in Patients with Platinum-Sensitive, Platinum-Resistant, and Platinum-Refractory Epithelial Ovarian Cancer
por: Cantón-Romero, Juan Carlos, et al.
Publicado: (2017)

Genetic Diversity and Population Structure of Cannabis Based on the Genome-Wide Development of Simple Sequence Repeat Markers
por: Zhang, Jiangjiang, et al.
Publicado: (2020)

Expression patterns of platinum resistance-related genes in lung adenocarcinoma and related clinical value models
por: Wang, Zhe, et al.
Publicado: (2022)

Homologous recombination deficiency (HRD) score in aggressive prostatic adenocarcinoma with or without intraductal carcinoma of the prostate (IDC-P)
por: Zhu, Sha, et al.
Publicado: (2022)

Predicting Treatment Response in Schizophrenia With Magnetic Resonance Imaging and Polygenic Risk Score
por: Wang, Meng, et al.
Publicado: (2022)

Homologous Recombination Deficiency (HRD) and BRCA 1/2 Gene Mutation for Predicting the Effect of Platinum-Based Neoadjuvant Chemotherapy of Early-Stage Triple-Negative Breast Cancer (TNBC): A Systematic Review and Meta-Analysis
por: Chai, Yue, et al.
Publicado: (2022)

Mutations in the Catalytic Loop HRD Motif Alter the Activity and Function of Drosophila Src64
por: Strong, Taylor C., et al.
Publicado: (2011)

SSH2.0: A Better Tool for Predicting the Hydrophobic Interaction Risk of Monoclonal Antibody
por: Zhou, Yuwei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_38a35q8cgr2aga4gd7rnmmmsh1